Centiva Capital’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,641
Closed -$380K 1890
2024
Q3
$380K Sell
14,641
-991
-6% -$24.6K 0.01% 1430
2024
Q2
$351K Buy
+15,632
New +$347K 0.01% 1381
2021
Q3
Sell
-14,701
Closed -$268K 1374
2021
Q2
$268K Buy
+14,701
New +$343K 0.01% 1088
2020
Q3
Sell
-11,666
Closed -$277K 747
2020
Q2
$277K Buy
+11,666
New +$270K 0.02% 427
2019
Q4
Sell
-32,604
Closed -$577K 843
2019
Q3
$577K Buy
+32,604
New +$660K 0.04% 295

Other funds holding EXEL

Centiva Capital's EXEL Position: Q4 2024 in Review

Centiva Capital sold out of Exelixis (EXEL) in Q4 2024, closing a stake of 14,641 shares — an estimated $380K sold.

Centiva Capital first reported a position in EXEL in Q3 2019 and held it in 5 quarters. The position peaked at $577K in Q3 2019. 520 funds tracked by Wall St. Rank hold EXEL as of Q4 2024.

  • Centiva Capital reported no remaining Exelixis position as of Q4 2024 after selling out during the quarter.
  • Centiva Capital sold 14,641 Exelixis shares in Q4 2024, an estimated $380K.
  • Centiva Capital first reported a position in Exelixis in Q3 2019 and held it in 5 quarters.
  • Centiva Capital's Exelixis position peaked at $577K in Q3 2019.
  • 520 funds tracked by Wall St. Rank held Exelixis as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.